Skip to main content
All lobbying filings

PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Lobbying for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

 Filing 4th Quarter - Report
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $50,000.00 expenses · posted Jan 16, 2026

Official filing document

 Lobbying activity 4
Health Issues

Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, workforce development, and potential impact of tariffs on domestic biopharmaceutical manufacturing.

Manufacturing

Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, workforce development, and potential impact of tariffs on domestic biopharmaceutical manufacturing.

Pharmacy

Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, workforce development, and potential impact of tariffs on domestic biopharmaceutical manufacturing.

Tariff (miscellaneous tariff bills)

Discussed response to Section 232 National Security Investigation of Imports of Pharmaceuticals and Pharmaceutical Ingredients

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem